nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abdelhamid H Elgazzar, Saud Alenezi (Eds). A concise guide to nuclear medicine. Second Edition
|
Mansi, Luigi |
|
|
48 |
4 |
p. 955 |
artikel |
2 |
A convolutional neural network for fully automated blood SUV determination to facilitate SUR computation in oncological FDG-PET
|
Nikulin, Pavel |
|
|
48 |
4 |
p. 995-1004 |
artikel |
3 |
A malignant birthmark detected by 18F-FDG PET/CT in a patient with esophageal cancer
|
Wang, Lijuan |
|
|
48 |
4 |
p. 1258-1259 |
artikel |
4 |
An unusual presentation of recurrent T cell lymphoma: angiocentric pattern of cutaneous uptake on [18F]FDG PET/CT
|
Guja, Kip E. |
|
|
48 |
4 |
p. 1256-1257 |
artikel |
5 |
A rare case of cranial and spinal leptomeningeal dissemination of recurrent ethmoid carcinoma detected by [18F]-FDG PET/CT
|
Yokoyama, Kota |
|
|
48 |
4 |
p. 1266-1267 |
artikel |
6 |
Brain insulin sensitivity is linked to body fat distribution—the positron emission tomography perspective
|
Rebelos, Eleni |
|
|
48 |
4 |
p. 966-968 |
artikel |
7 |
Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study
|
Canosa, Antonio |
|
|
48 |
4 |
p. 1124-1133 |
artikel |
8 |
Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer’s disease cases
|
Malarte, Mona-Lisa |
|
|
48 |
4 |
p. 1093-1102 |
artikel |
9 |
Detection of pseudoprogression with [18F]-FDG-PET in a patient with pulmonary large cell neuroendocrine carcinoma who received anti-PD-1 treatment
|
Yamaguchi, Ou |
|
|
48 |
4 |
p. 1268-1270 |
artikel |
10 |
Diffuse multiple organs uptake of 99mTc-MDP on SPECT/CT
|
Jiang, Maoqing |
|
|
48 |
4 |
p. 1264-1265 |
artikel |
11 |
EANM procedural guidelines for PET/CT quantitative myocardial perfusion imaging
|
Sciagrà, Roberto |
|
|
48 |
4 |
p. 1040-1069 |
artikel |
12 |
EANM/SNMMI practice guideline for [18F]FDG PET/CT external beam radiotherapy treatment planning in uterine cervical cancer v1.0
|
Adam, Judit A. |
|
|
48 |
4 |
p. 1188-1199 |
artikel |
13 |
Expert consensus on the safety prevention and control of nuclear medicine diagnosis and treatment during the outbreak of COVID-19 (1st edition): (translated from Chinese version)
|
Lan, Xiaoli |
|
|
48 |
4 |
p. 1134-1143 |
artikel |
14 |
18F-FDG PET/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry study
|
Kirchner, Julian |
|
|
48 |
4 |
p. 1154-1165 |
artikel |
15 |
18F-FDG simultaneous PET/MR monitoring treatment response of a Turcot syndrome case
|
Wang, Haiyan |
|
|
48 |
4 |
p. 1252-1253 |
artikel |
16 |
[68Ga]Ga-DOTA-FAPI-04 PET/CT imaging in a case of prostate cancer with shoulder arthritis
|
Xu, Tingting |
|
|
48 |
4 |
p. 1254-1255 |
artikel |
17 |
[68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy: a novel technique for sentinel lymph node imaging
|
Mahieu, Rutger |
|
|
48 |
4 |
p. 963-965 |
artikel |
18 |
[68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy for sentinel lymph node detection in early-stage oral cavity carcinoma
|
Mahieu, Rutger |
|
|
48 |
4 |
p. 1246-1247 |
artikel |
19 |
Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative SPECT
|
Gosewisch, A. |
|
|
48 |
4 |
p. 1260-1261 |
artikel |
20 |
Improved cancer detection in Waldeyer’s tonsillar ring by 68Ga-FAPI PET/CT imaging
|
Serfling, S. |
|
|
48 |
4 |
p. 1178-1187 |
artikel |
21 |
Improved oncological outcome after radical prostatectomy in patients staged with 68Ga-PSMA-11 PET: a single-center retrospective cohort comparison
|
Ferraro, Daniela A. |
|
|
48 |
4 |
p. 1219-1228 |
artikel |
22 |
Improving staging of rectal cancer in the pelvis: the role of PET/MRI
|
Catalano, Onofrio A. |
|
|
48 |
4 |
p. 1235-1245 |
artikel |
23 |
Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension
|
Frille, Armin |
|
|
48 |
4 |
p. 1081-1092 |
artikel |
24 |
In the era of FDG PET, is it time for brain perfusion SPECT to gain a place in Alzheimer’s disease imaging biomarkers?
|
Valotassiou, Varvara |
|
|
48 |
4 |
p. 969-971 |
artikel |
25 |
IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab—pharmacokinetic modeling to optimize therapeutic index
|
Yerrabelli, Rahul S. |
|
|
48 |
4 |
p. 1166-1177 |
artikel |
26 |
Multiparametric PET and MRI of myocardial damage after myocardial infarction: correlation of integrin αvβ3 expression and myocardial blood flow
|
Makowski, Marcus R. |
|
|
48 |
4 |
p. 1070-1080 |
artikel |
27 |
Optimal 68Ga-PSMA and 18F-PSMA PET window levelling for gross tumour volume delineation in primary prostate cancer
|
Draulans, Cédric |
|
|
48 |
4 |
p. 1211-1218 |
artikel |
28 |
Preclinical evaluation of 5-methyltetrahydrofolate-based radioconjugates—new perspectives for folate receptor–targeted radionuclide therapy
|
Guzik, Patrycja |
|
|
48 |
4 |
p. 972-983 |
artikel |
29 |
Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM
|
Slart, Riemer H. J. A. |
|
|
48 |
4 |
p. 1016-1039 |
artikel |
30 |
Promising potential of [177Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy—a preclinical study using a syngeneic breast cancer model
|
Guzik, Patrycja |
|
|
48 |
4 |
p. 984-994 |
artikel |
31 |
PSMA PET total tumor volume predicts outcome of patients with advanced prostate cancer receiving [177Lu]Lu-PSMA-617 radioligand therapy in a bicentric analysis
|
Seifert, Robert |
|
|
48 |
4 |
p. 1200-1210 |
artikel |
32 |
Random survival forest to predict transplant-eligible newly diagnosed multiple myeloma outcome including FDG-PET radiomics: a combined analysis of two independent prospective European trials
|
Jamet, Bastien |
|
|
48 |
4 |
p. 1005-1015 |
artikel |
33 |
Response to 225Ac-PSMA-I&T after failure of long-term 177Lu-PSMA RLT in mCRPC
|
Ilhan, Harun |
|
|
48 |
4 |
p. 1262-1263 |
artikel |
34 |
Risk of relapse after anti-PD1 discontinuation in patients with Hodgkin lymphoma
|
Manson, G. |
|
|
48 |
4 |
p. 1144-1153 |
artikel |
35 |
Safety and tolerability of 68Ga-NT-20.3, a radiopharmaceutical for targeting neurotensin receptors, in patients with pancreatic ductal adenocarcinoma: the first in-human use
|
Hodolic, Marina |
|
|
48 |
4 |
p. 1229-1234 |
artikel |
36 |
Sigma-1 and dopamine D2/D3 receptor occupancy of pridopidine in healthy volunteers and patients with Huntington disease: a [18F] fluspidine and [18F] fallypride PET study
|
Grachev, Igor D. |
|
|
48 |
4 |
p. 1103-1115 |
artikel |
37 |
The critical role of FDG-PET/CT imaging in assessing systemic manifestations of COVID-19 infection
|
Alavi, Abass |
|
|
48 |
4 |
p. 956-962 |
artikel |
38 |
The superiority of [68Ga]-FAPI-04 over [18F]-FDG PET/CT in imaging metastatic esophageal squamous cell carcinoma
|
Liu, Qiufang |
|
|
48 |
4 |
p. 1248-1249 |
artikel |
39 |
The use of 18F-FDG PET/CT to guide management of adrenal histoplasmosis over time
|
Parisien-La Salle, S. |
|
|
48 |
4 |
p. 1250-1251 |
artikel |
40 |
Visual interpretation of [18F]Florbetaben PET supported by deep learning–based estimation of amyloid burden
|
Kim, Ji-Young |
|
|
48 |
4 |
p. 1116-1123 |
artikel |